Personalized Gene Therapy Treatment Market Growth Outlook Shows Steady Expansion At A 20.4% CAGR Through 2030

 The Business Research Company’s 2026 market reports incorporate enhanced features, including market attractiveness scoring and analysis, total addressable market evaluation, a company scoring matrix, an interactive Excel data dashboard, refined supply chain analysis, insights on emerging startups, and overviews of key products, all aimed at improving the depth, usability, and strategic relevance of the insights delivered.

 
 What Is The Expected Market Size Of The Personalized Gene Therapy Treatment Market Across The Forecast Years?
 The personalized gene therapy treatment market size has grown exponentially in recent years. It will grow from $8.38 billion in 2025 to $10.11 billion in 2026 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing prevalence of genetic disorders, advancements in genomic sequencing technologies, early clinical success of targeted gene therapies, expansion of specialized gene therapy research centers, increasing investment in precision medicine.
 
 The personalized gene therapy treatment market size is expected to see exponential growth in the next few years. It will grow to $21.23 billion in 2030 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to increasing regulatory approvals for personalized gene therapies, rising demand for customized oncology treatments, expansion of gene therapy manufacturing capabilities, growing integration of AI in therapy design, increasing adoption of pharmacogenomics-guided treatments. Major trends in the forecast period include increasing adoption of gene editing-based therapies, rising use of personalized treatment protocols, growing integration of companion diagnostics, expansion of viral and non-viral vector platforms, enhanced focus on precision oncology applications.
 
 Download Your Free Report Sample:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28293&type=smp
 
 Which Factors Are Expected To Fuel The Personalized Gene Therapy Treatment Market In The Coming Years?
 The growing prevalence of genetic disorders is expected to propel the growth of the personalized gene therapy treatment market going forward. Genetic disorders are conditions resulting from DNA abnormalities that disrupt normal body functions. The prevalence of genetic disorders is rising due to increasing parental age, as older reproductive cells have a higher risk of mutations that can be passed to offspring. Personalized gene therapy addresses genetic disorders by precisely correcting the defective genes responsible for the condition and tailors treatment to an individual’s genetic makeup, enhancing efficacy and reducing side effects. For instance, in October 2024, according to Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, in 2022, around 11,148 cystic fibrosis (a genetic disorder) patients were registered, and this number grew to 11,318 in 2023, reflecting a 1.5% increase in patient registrations year over year Therefore, the growing prevalence of genetic disorders is driving the growth of the personalized gene therapy treatment market. 
 
 Who Are The Most Influential Companies In The Personalized Gene Therapy Treatment Market?
 The personalized gene therapy treatment market covered in this report is segmented — 
 
 1) By Therapy: Targeted Treatments, Pharmacogenomics
 2) By Vector Type: Viral, Non-Viral
 3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels
 4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications
 
 Subsegments:
 1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy
 2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction
 
 What Key Trends Are Expected To Reshape The Personalized Gene Therapy Treatment Market Landscape?
 Major companies operating in the personalized gene therapy treatment market are focusing on adopting strategic partnerships to expand technological capabilities and bring innovative therapies to patients more efficiently. Strategic partnerships are collaborative alliances between organizations to leverage each other’s strengths and resources for mutual growth and competitive advantage while sharing risks and benefits. For instance, in May 2025, Aldevron, a US-based company involved in the production of DNA, RNA, and protein, collaborated with Integrated DNA Technologies, a US-based provider of genomics solutions, to manufacture the world’s first mRNA-based personalized CRISPR therapy to treat an infant with a rare and life-threatening genetic condition, urea cycle disorder (UCD). This N of 1 therapy was developed and delivered in just six months by creating a custom guide RNA, an mRNA-encoded base editor, off-target safety services, and a clinically validated lipid nanoparticle delivery system. The therapy’s development marks a significant milestone in personalized in vivo base-editing treatments.
 
 What Emerging Segments Are Influencing The Personalized Gene Therapy Treatment Market?
 The personalized gene therapy treatment market covered in this report is segmented — 
 
 1) By Therapy: Targeted Treatments, Pharmacogenomics
 2) By Vector Type: Viral, Non-Viral
 3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels
 4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications
 
 Subsegments:
 1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy
 2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction
 
 Explore the Complete Personalized Gene Therapy Treatment Market Report:
 https://www.thebusinessresearchcompany.com/report/personalized-gene-therapy-treatment-global-market-report
 
 Which Region Is Expected To Hold The Largest Share Of The Personalized Gene Therapy Treatment Market?
 https://www.thebusinessresearchcompany.com/report/personalized-gene-therapy-treatment-global-market-report
 
 #Contact Us:#
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: marketing@tbrc.info
 
 #Follow Us On:#
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company